Home

News2

Verséa Ophthalmics and Celularity Announce Exclusive U.S. Commercialization Agreement to Distribute Biovance® and Biovance® 3L Ocular for Ophthalmic Applications
Ophthalmics

Verséa Ophthalmics and Celularity Announce Exclusive U.S. Commercialization Agreement to Distribute Biovance® and Biovance® 3L Ocular for Ophthalmic Applications

July 27, 2023by Tristen Koerber

TAMPA, FL. and FLORHAM PARK, N.J., July 27, 2023 — Verséa Ophthalmics, LLC (“Verséa Ophthalmics”), a Tampa, FL-based company that focuses on providing complete ocular point-of-care diagnostic and therapeutic interventions, and Celularity Inc. (Nasdaq: CELU) (“Celularity”), a biotechnology company developing placental-derived allogeneic cell therapies and biomaterial products, today announced that the companies have entered into...

READ MORE
Verséa Ophthalmics Commences Phase 1 Launch of Novel Tear-based Point-of-Care (T-POC) Quantitative Testing Platform
Ophthalmics

Verséa Ophthalmics Commences Phase 1 Launch of Novel Tear-based Point-of-Care (T-POC) Quantitative Testing Platform

July 25, 2023by Tristen Koerber

7/25/2022, Tampa, FL – Verséa™ Ophthalmics, LLC, a division of Verséa Health, Inc. committed to delivering novel, high-value diagnostic and therapeutic solutions to improve ocular disease, proudly announces the commencement of initial shipments of its T-POC TOTAL IgE Immunoassay and Lateral Flow  Readers. The company focuses on delivering innovative Tear-based Point-of-Care (T-POC) testing and biologic solutions that...

READ MORE
Verséa Health and iRemedy Announce Strategic Joint Venture
CorporateDiagnostics

Verséa Health and iRemedy Announce Strategic Joint Venture

June 28, 2023by Verséa Health

Tampa, FL – June 28, 2023 – Verséa Health, Inc., a prominent provider of diagnostics and medical supplies for urgent care centers, and iRemedy Healthcare Companies, Inc. (“iRemedy”), a trailblazer in the medical supply e-commerce industry, are thrilled to announce their strategic joint venture. The collaboration aims to establish an integrated ecosystem of services tailored...

READ MORE
Verséa Health and Doc Johnson to Launch Wellness Center for Retailers
CorporateDiagnostics

Verséa Health and Doc Johnson to Launch Wellness Center for Retailers

June 15, 2023by Natasha Svast

Tampa, FL. — Verséa Health, Inc. has partnered with Doc Johnson to launch a new Doc Johnson Wellness Center display available to retailers. This exclusive new partnership will provide Doc Johnson customers with access to cutting-edge diagnostics, treatments and preventive care services that are tailored to their individual needs. The Doc Johnson Wellness Center will include...

READ MORE
Uncovering The Truth Behind Healthcare Systems with Sean Fetcho, Co-Founder & CEO of Verséa™ Health
Corporate

Uncovering The Truth Behind Healthcare Systems with Sean Fetcho, Co-Founder & CEO of Verséa™ Health

March 7, 2023by Verséa Diagnostics

We are pleased to announce that our Co-Founder and CEO, Sean Fetcho, was recently featured as a guest on the Healthcare Executive Insights Podcast, presented by The Macallan Group. The latest episode titled “Uncovering The Truth Behind Healthcare Systems” is now available for streaming on YouTube, Spotify, and Apple Podcasts. During the podcast, Sean shares...

READ MORE
Verséa™ Biologics at the North American Neuromodulation Society 26th Annual Meeting
BiologicsTherapeutics

Verséa™ Biologics at the North American Neuromodulation Society 26th Annual Meeting

January 16, 2023by Natasha Svast

Members of our Verséa Biologics team (Sunil Panchal, MD, Chief Scientific Officer, Verséa Biologics; David Kloth, M.D., Medical Director, Verséa Biologics; and Bill Bigham, VP of Sales, Verséa Biologics) attended this year’s North American Neuromodulation Society 26th Annual Meeting. At the event they had a chance to present our innovative portfolio of Biologics products which...

READ MORE
Verséa™ Ophthalmics at the Hawaii Eye 2023
Ophthalmics

Verséa™ Ophthalmics at the Hawaii Eye 2023

January 7, 2023by Natasha Svast

Verséa Ophthalmics invites you to attend the Hawaiian Eye 2023 – Disruptive Innovations Symposium on January 16th from 1pm – 2:30pm HST where Dr. Rob Sambursky, our President, will be presenting the latest Eye Care innovations: Novel, Tear-based Point-of-care (POC) diagnostic platform with 2 quantitative tests, Complementary regenerative therapeutics. These innovative solutions will help you...

READ MORE

Older Posts

Subscribe to the Verséa Membership Club

Receive exclusive membership offers, discounts and latest industry insights, free of charge.

Subscribe to the Verséa Membership Club

Receive exclusive membership offers, discounts and latest industry insights, free of charge.
[hubspot type=form portal=20074237 id=4147b977-36b5-4704-8428-ecd033cf2203]
https://www.versea.com/wp-content/uploads/2021/02/new_logo.png
1-800-397-0670
Contact Us
401 S. Florida Ave, Tampa, FL 33602

© 2022 Verséa Health, Inc. All rights reserved.

Explore Verséa

News